Company Team

Company Team

Co-Founder & President

Mr. Lei Chen

Mr. Lei Chen


  • 20+ yrs of operating management experience and resource integration ability in pharmaceutical enterprises
  • Former Executive Vice president/Director of Hunan Jinsha Pharmaceutical Co., LTD., and led the listing of Jinsha Pharmaceutical
  • Shareholders and directors of multiple proposed listed companies

Co-Founder & CEO

Dr. Sean Li

Dr. Sean Li


  • 30+ yrs experience in  peptide chemistry and  biology
  • 10 yrs CRO experience in  peptide technology and  services. Former Exec. Director of Peptide  Technology and Services in  WuXi AppTec
  • Ph.D. in Chemistry from  Peking University; Postdoc  at Purdue, University of  Maryland and Osaka  University

Co-Founder & Senior Vice President

Mr. Huanzhang Gong

Mr. Huanzhang Gong


  • 20+ yrs of experience in pharmaceutical enterprise operation and management
  • Former General Manager of Hunan Jinsha Pharmaceutical Trading Company;Sales Manager of Zhuhai Tianda Pharmaceutical
  • Has invested in Jinsha Pharmaceutical, Anxin Biological, Huateng Pharmaceutical, Yuanxu Optoelectronics and other companies (financial investment)

Executive Director, R&D Strategy

Dr. Wenge Liu

Dr. Wenge Liu


  • 20+ yrs of industrial and  academic research  experience in DMPK, drug  delivery life cycle  management
  • Former V.P. of Hainan R&D  Center at Simcere Pharma;  Senior Director of DPMK at  Senior Director of DMPK  Suzhou Wuxi AppTech;  Research Professor,  Biomedical Engineering,  Duke University
  • M.D. in Medicine from Tianjin  Medical University and PhD  in Pharmaceutical Sciences  from Kumamoto University

Senior Vice President Drug Discovery

Dr. Henry Liu

Dr. Henry Liu


  • 25+ yrs of industrial research  and management experience  in drug screening,  pharmacology from early  discovery to preclinical late  stage
  • Former Director of  Neurorscience in  Chempartner; V.P. of Biology  in PharmaCore Labs;  Scientist at Icagen Inc. & Neuromed
  • M.D. in Clinical  Medicine/Cardiac Surgery  from Peking University

Vice President

Mr.Xinbo Wang

Mr.Xinbo Wang


  • Former R&D Director of Chengdu Shengnuo
  • Former Director of Peptide Technology and Service Department at WuXi AppTec
  • Former R&D manager of Kingsrui Peptide Department

Executive Director, In Vitro Biology

Dr. Shiu-Feng  Tung

Dr. Shiu-Feng Tung


  • 20+ yrs of industrial and academic  research experience in high  throughput screening, assay  development and receptor pharmacology
  • Former Senior Dzirector of  R&D at Tripartite Therapeutics; Supervisor of Taipai  Facility at Arena Pharmaceuticals; Director of High  Throughput Screening and  Receptor Pharmacology at TaiGen  Biotechnology; Principal  Investigator of GPCR Project at  Development Center for  Biotechnology
  • Ph.D. in Life Science from Institute  of Life Science, Academia  Sinica/National Health Research  Institute/National Defense Medical  Center Joint Program

Vice President, R&D Strategy

Dr. Yantao He

Dr. Yantao He


  • He is a highly experienced peptide medicinal chemist with over 20 years of expertise in academia and the pharmaceutical industry
  • He has served as Senior Director of Peptide Chemistry at GeneScience Pharmaceuticals and played key roles in drug discovery at Neurocrine Biosciences, Novo Nordisk Research Center Indianapolis (NNRCI), and Indiana University School of Medicine
  • He holds a Ph. D. from Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences

Deputy General Advisor, R&D Strategy

Dr. Quiyun Dai

Dr. Quiyun Dai


  • a Ph.D. degree in Beijing Institute of Pharmaceutical Chemistry, worked as a postdoctoral fellow in Beijing Institute of Biotechnology and in the Department of Chemistry and Biochemistry at the University of Notre Dame
  • Former vice president of Discovery Chemistry of Shanghai ChemPartner, the director, principal investigator (professor) and doctoral supervisor of the Peptide Chemistry Laboratory of the Academy of Military Medical Sciences
  • Completed a number of clinical or preclinical studies of Class I innovative drugs, and is familiar with peptide and small molecule drug design, synthesis (including large-scale manufacture), quality study, pharmacology and drug application process

Senior Director, Medicinal Chemistry

Dr. Yilong Li

Dr. Yilong Li


  • 10+ years of peptide drug  development experience,  team leading experience  from target/indication  selection to PCC/IND
  • Former Senzior Principal Scientist at Jiangsu Hengrui  Medicine Co.,Senior  Scientist at Creative  Peptides, Development  Scientist PolyPeptide Group
  • PhD in Pharmaceutical  Sciences at USC
< 12 > proceed page
LOGO